Statement of Ownership (sc 13g)
June 05 2017 - 5:00PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act
of 1934
Pulse
Biosciences, Inc.
(Name of Issuer)
Common Stock,
$0.001 par value per share
(Title of Class of Securities)
74587B 10 1
(CUSIP Number)
December 31,
2016
(Date of Event Which Requires Filing of this
Statement)
Check the appropriate box to designate
the rule pursuant to which this Schedule is filed:
[ ]
|
Rule 13d-1(b)
|
[ ]
|
Rule 13d-1(c)
|
[X]
|
Rule 13d-1(d)
|
*The remainder of this cover page shall be filled out for a reporting person’s initial filing
on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required
in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities
Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject
to all other provisions of the Act (however, see the Notes).
CUSIP
No. 74587B 10 1
|
|
1.
|
Names
of Reporting Person:
Mark E. Strome
|
|
2.
|
Check the Appropriate Box if a
Member of a Group (See Instructions)
|
|
|
(a)
|
[ ]...................................................................................................................................................
|
|
|
(b)
|
[ ]...................................................................................................................................................
|
|
3.
|
SEC Use Only ..........................................................................................................................................
|
|
4.
|
Citizenship
or Place of Organization
United States of America
|
Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
|
|
|
5.
|
Sole Voting Power
1,164,829 (1)
|
6.
|
Shared Voting Power
0
|
7.
|
Sole Dispositive Power 1,164,829
(1)
|
8.
|
Shared Dispositive Power 0
|
|
9.
|
Aggregate Amount Beneficially Owned
by Each Reporting Person 1,164,829 (1)
|
|
10.
|
Check
if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
[ ].............................................................................................................................................................
|
|
11.
|
Percent of Class Represented by
Amount in Row (9) 8.2%
|
|
12.
|
Type of Reporting Person (See Instructions) IN
|
|
|
(1)
|
Consists
of 1,164,829 shares of Common Stock held of record by the Mark and Tammy Strome Family
Trust U/A/D August 18, 2008 (the “Trust”). Mr. Strome and Tammy Estrada Strome
are the co-trustees of the Trust under the applicable trust agreement. However, Mr. Strome
was granted primary management and control of the assets owned by the Mark and Tammy
Strome Family Trust, including the subject shares of Common Stock, pursuant to an order
entered on January 18, 2017 by the Superior Court of California, County of Los Angeles,
Case No. BD 636746 in the action entitled In re the Marriage of Strome.
|
ITEM 1.
(a)
NAME
OF ISSUER
.
Pulse
Biosciences, Inc.
(b)
ADDRESS
OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES
.
849
Mitten Rd #104
Burlingame, CA 94010
ITEM 2.
(a)
NAME
OF PERSONS FILING
.
Mark E.
Strome
(b)
ADDRESS
OF PRINCIPAL BUSINESS OFFICE
.
100
Wilshire Blvd., Suite 1500
Santa Monica, CA 90401
(c)
CITIZENSHIP
.
United
States
(d)
TITLE
OF CLASS OF SECURITIES
.
Common
Stock, $0.001 par value per share
(e)
CUSIP
NUMBER
.
74587B
10 1
ITEM 4.
OWNERSHIP
.
(a) Amount
beneficially owned: 1,164,829
(b) Percent
of class: 8.2%
(c) Number
of shares as to which the reporting person has:
(i) Sole
power to vote or to direct the vote: 1,164,829
|
(ii)
|
Shared
power to vote or to direct the vote: 0
|
|
(iii)
|
Sole
power to dispose or to direct the disposition of: 1,164,829
|
|
(iv)
|
Shared
power to dispose or to direct the disposition of: 0
|
ITEM 5.
OWNERSHIP
OF FIVE PERCENT OR LESS OF A CLASS
.
If this
statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner
of more than five percent of the class of securities, check the following: □
ITEM 6.
OWNERSHIP
OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
.
Mr. Strome
and Ms. Estrada Strome are the co-trustees of the Trust, and under the terms of the trust agreement are each able to direct the
dividends from, or proceeds from the sale of, the Common Stock of Pulse Biosciences. However, Mr. Strome was granted primary management
and control of the assets owned by the Mark and Tammy Strome Family Trust, including the subject shares of Common Stock, pursuant
to an order entered on January 18, 2017 by the Superior Court of California, County of Los Angeles, Case No. BD 636746 in the
action entitled In re the Marriage of Strome.
|
ITEM 7.
|
IDENTIFICATION
AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY
THE PARENT HOLDING COMPANY OR CONTROL PERSON
.
|
Not applicable
ITEM 8.
IDENTIFICATION
AND CLASSIFICATION OF MEMBERS OF THE GROUP
.
Not applicable.
ITEM 9.
NOTICE
OF DISSOLUTION OF GROUP
.
Not applicable.
|
ITEM 10.
|
CERTIFICATIONS
.
|
Not
applicable.
SIGNATURE
After
reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.
Pulse Biosciences (NASDAQ:PLSE)
Historical Stock Chart
From Apr 2024 to May 2024
Pulse Biosciences (NASDAQ:PLSE)
Historical Stock Chart
From May 2023 to May 2024